Format

Send to

Choose Destination
Drug Discov Today. 2009 May;14(9-10):442-5. doi: 10.1016/j.drudis.2009.01.010. Epub 2009 Feb 11.

Patent holdings of US biotherapeutic companies in major markets.

Author information

1
Institute of Bioinformatics and Applied Biotechnology, NEN-Wadhwani Centre of Excellence in Entrepreneurship Education, G-05 Tech Park Mall, ITPB, Whitefield Road, Bangalore 560066, India.

Abstract

In previous studies we examined the (United States, US) patent holdings of 109 largely North American biotech companies developing therapeutics that, in particular, have an interest in discovery stage science. There appears little correlation between the number of patents and the number of products of individual companies. Here we quantified and compared the 103 US-headquartered companies' patent holdings in Australia, Canada, Europe, Japan and the US. The companies demonstrate variable and surprising patterns of patent holdings across these countries or regions. For most companies, patent holdings are not in proportion to the importance of the country as a biotech or pharma market. These results have implications for the patenting strategies of small biotech companies involved in drug discovery.

PMID:
19429502
DOI:
10.1016/j.drudis.2009.01.010
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center